| CTRI Number |
CTRI/2025/01/079126 [Registered on: 21/01/2025] Trial Registered Prospectively |
| Last Modified On: |
18/05/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Study of Dexamethasone as an Adjuvant to Levobupivacaine for analgesic efficacy in Infraclavicular Brachial Plexus Block in patients undergoing Upper Limb Surgery |
|
Scientific Title of Study
|
Study of Dexamethasone as an Adjuvant to Levobupivacaine for Analgesic efficacy in Infraclavicular Brachial Plexus Block in patients undergoing Upper Limb Surgery |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Sarvjeet Kaur |
| Designation |
Professor and Head |
| Affiliation |
GGSMCH, Faridkot |
| Address |
Department of Anaesthesia, GGSMCH, Faridkot, Punjab, India, 151203
Faridkot PUNJAB 151203 India |
| Phone |
9915680508 |
| Fax |
|
| Email |
drsarvjeetk@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Sarvjeet Kaur |
| Designation |
Professor and Head |
| Affiliation |
GGSMCH, Faridkot |
| Address |
Department of Anaesthesia, GGSMCH, Faridkot, Punjab, India, 151203
Faridkot PUNJAB 151203 India |
| Phone |
9915680508 |
| Fax |
|
| Email |
drsarvjeetk@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Sarvjeet Kaur |
| Designation |
Professor and Head |
| Affiliation |
GGSMCH, Faridkot |
| Address |
Department of Anaesthesia, GGSMCH, Faridkot, Punjab, India, 151203
Faridkot PUNJAB 151203 India |
| Phone |
9915680508 |
| Fax |
|
| Email |
drsarvjeetk@gmail.com |
|
|
Source of Monetary or Material Support
|
| Department of Anaesthesia, GGSMCH, Faridkot, Punjab, India, 151203 |
|
|
Primary Sponsor
|
| Name |
Dr Sarvjeet Kaur |
| Address |
Department of Anaesthesia, GGSMCH, Faridkot, Punjab |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| Dr Mukesh Kumar |
Department of Anaesthesia, GGSMCH, Faridkot, Punjab |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Faheem P |
Guru Gobind Singh Medical College and Hospital |
Department of Anaesthesia, GGSMCH, Faridkot, Punjab, India, 151203 Faridkot PUNJAB |
9531957808
faheemp196@yahoo.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Ethics committee ofGGSMCH Faridkot |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: M959||Acquired deformity of musculoskeletal system, unspecified, (2) ICD-10 Condition: X92-Y09||Assault, (3) ICD-10 Condition: M96-M96||Intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Perineural Levobupivacaine |
To evaluate the duration of analgesia with perineural Levobupivacaine in Infraclavicular Brachial Plexus Block for upper limb surgeries |
| Intervention |
Perineural Levobupivacaine with Dexamethasone |
To evaluate the duration of analgesia with perineural Levobupivacaine with Dexamethasone in Infraclavicular Brachial Plexus Block for upper limb surgeries |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
1. Patients with American Society of Anaesthesiologists grade I and II
2. Patients between age of 18-60 years, giving valid informed and written consent |
|
| ExclusionCriteria |
| Details |
1. Patients with inability to comprehense pain
2. Patients who have allergy to study drugs
3. Patients with local site infections
4. Patients having coagulation abnormalities
5. Patients who are on prolonged analgesics |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Duration of sensory and motor Block |
Every 1 hr till it resolves |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Quality of analgesia |
Every 1 hr till it resolves |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 1/ Phase 2 |
|
Date of First Enrollment (India)
|
05/02/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
Modification(s)
|
We aim to evaluate the role of perineural dexamethasone as an adjuvant along with levobupivacaine in infraclavicular brachial plexus block for upper limb surgeries. The study will be conducted in a randomized, controlled manner in the Department of Anaesthesiology, GGS Medical College and Hospital, Faridkot on patients of age between 18 to 60 years, American Society of Anaesthesiologists Grade I and II, scheduled to undergo below elbow surgeries. The total patients 60 will be randomly allocated into groups of 30 patients each. Group LB:-will receive 25 ml drug (24 ml 0.5% levobupivacaine + 1 ml NS) Group LD:- will receive 25 ml drug (24ml 0.5% levobupivacaine plus 1 ml dexamethasone(4mg) |